Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 8, 2020C-*Albumin Eye Drop 10% SLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Medical Center Pharmacy, Inc. · D-1073-2020Class IITerminatedApr 8, 2020Gentamicin 80mg/60 mL IrrigationLack of Assurance of SterilityThe Medicine Shoppe Pharmacy · D-1072-2020Class IITerminatedApr 8, 2020Glycopyrrolate TabletsFailed Impurities/Degradation Specification: Presence of unknown impurity observed.Par Pharmaceutical Inc. · D-1071-2020Class IITerminatedApr 1, 2020Advil Liqui-Gel Mini 160+20+20 CTLabeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.Glaxosmithkline Consumer Healthcare Holdings · D-1069-2020Class IITerminatedApr 1, 2020Advil Sinus Congestion and Pain/Advil Allergy and Congestion Relief 8 pc with $1 IRCLabeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.Glaxosmithkline Consumer Healthcare Holdings · D-1068-2020Class IITerminatedApr 1, 2020Ibuprofen 50 mg per 1.25 mL Oral Suspension Advil Infant Concentrated Drops White Grape 0.75 oz. and 1 oz...Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.Glaxosmithkline Consumer Healthcare Holdings · D-1067-2020Class IITerminatedApr 1, 2020Ibuprofen 200 mg liquid filled capsules Advil Liqui-Gel MinisLabeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.Glaxosmithkline Consumer Healthcare Holdings · D-1066-2020Class IITerminatedApr 1, 2020Ibuprofen 200 mg Chlorpheniramine Maleate 4mg Phenylephrine 10 mg tablets. Advil Allergy & Congestion Relief...Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.Glaxosmithkline Consumer Healthcare Holdings · D-1065-2020Class IITerminatedApr 1, 2020DRAXIMAGE DTPAFailed Stability SpecificationsJubilant Draximage Inc · D-1062-2020Class IITerminatedApr 1, 2020Nystatin Oral SuspensionSubPotent Drug: Low out-of-specification results for assay testing.PAI Holdings, LLC. dba Pharmaceutical Associates Inc · D-1060-2020Class IITerminatedApr 1, 2020TheophyllineCGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and...Nostrum Laboratories Inc · D-1059-2020Class IIITerminatedApr 1, 2020Tacrolimus CapsulesPresence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.Mylan Pharmaceuticals Inc. · D-1057-2020Class IITerminatedApr 1, 2020Buprenorphine Black Cherry 2 mg TrocheSubpotent DrugMatthew 7:25 Inc dba Thrive Pharmacy · D-1054-2020Class IITerminatedApr 1, 2020Buprenorphine Watermelon 8 mg TrocheSubpotent DrugMatthew 7:25 Inc dba Thrive Pharmacy · D-1053-2020Class IITerminatedApr 1, 2020Buprexone Banana cream 6-0.6 mg TrocheSubpotent DrugMatthew 7:25 Inc dba Thrive Pharmacy · D-1052-2020Class IIITerminatedApr 1, 2020ColostatLabeling mix-up - Indications on product label are incorrect.Grato Holdings, Inc. · D-1049-2020Class IITerminatedMar 25, 2020Sodium Chloride 0.9% InjectionCGMP Deviation: Chemical indicators were not positioned properly during sterilization process.Fresenius Medical Care Holdings, Inc. · D-1064-2020Class IITerminatedMar 25, 2020Pantoprazole Sodium Delayed-Release TabletsCGMP Deviations: Presence of dark brown discoloration on edges of tabletsJubilant Cadista Pharmaceuticals, Inc. · D-1058-2020Class IITerminatedMar 25, 2020Solifenacin Succinate TabletsCGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.Breckenridge Pharmaceutical, Inc · D-1051-2020Class IITerminatedMar 25, 2020Solifenacin Succinate TabletsCGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.Breckenridge Pharmaceutical, Inc · D-1050-2020Class IITerminatedMar 25, 2020Atorvastatin Calcium TabletsPresence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.Sun Pharmaceutical Industries, Inc. · D-1047-2020Class IITerminatedMar 25, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1045-2020Class IITerminatedMar 25, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1044-2020Class IITerminatedMar 25, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1043-2020Class IITerminatedMar 25, 2020DaytranaDefective Delivery System: Out of specification for mechanical peel and shear.Noven Therapeutics, LLC · D-1042-2020Class ITerminatedMar 25, 2020Bow & ArrowMarketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.Med Man Distribution, Inc. · D-1037-2020Class ITerminatedMar 25, 2020UP2, Dietary SupplementMarketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.Med Man Distribution, Inc. · D-1036-2020Class IIITerminatedMar 25, 2020PrediniSONE TabletsLabeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Prednisone Tablets USP 5 mgPar Pharmaceutical Inc. · D-1035-2020Class IITerminatedMar 25, 2020Doxycycline CapsulesCGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.Sun Pharmaceutical Industries, Inc. · D-1033-2020Class IITerminatedMar 25, 2020Doxycycline CapsulesCGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.Sun Pharmaceutical Industries, Inc. · D-1032-2020Class IITerminatedMar 25, 2020Sotalol HCL TabletsPresence of particulate matter. presence of metal particles.Mylan Pharmaceuticals Inc. · D-1031-2020Class IITerminatedMar 25, 2020Lisinopril/HCTZ 20mg/12.5mg TabletPresence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500...RemedyRepack Inc. · D-1030-2020Class IIITerminatedMar 25, 2020Potassium Chloride Extended-Release Tablets USPFailed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.Strides Pharma Science Limited · D-1029-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1028-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1027-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1026-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1025-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1024-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1023-2020Class IITerminatedMar 25, 2020Maximum Strength Acid ReducerCGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.Perrigo Company PLC · D-1022-2020